|
|
Cresco Labs Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/28/2026 15:54
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization403.84 mln
Float346 mln
Earnings Date08/06/2026
Relative Strength
20
/ 100
Significantly lagging
Key Fundamentals
EPS-0.54
ROE-33.05
RPS2.46
ROIC6.61
ROA-10.41
Interest Cover1.24
EBITDA, mln24.28
EV / EBITDA44.80
EV / EBIT-21.09
Revenue, mln882
EV / Revenue1.23
Financial Strength
Altman Z-Score-0.99
Piotroski F-Score
4
/ 9
Beneish M-Score-2.91
Price to Intrinsic Value2.66
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-10% |
26
/ 100
 |
| 1 Month |
-21.74% |
26
/ 100
|
| 2 Months |
-29.69% |
41
/ 100
 |
| 6 Months |
-41.18% |
37
/ 100
 |
| 1 Year |
-3.23% |
64
/ 100
 |
|
| |
